155271-59-3 Usage
Type of compound
Synthetic compound
Application
Treatment of hormone receptor-positive breast cancer
Mechanism of action
Selective estrogen receptor degrader
Function
Inhibits the activity of estrogen and blocks its effects on breast cancer cells
Classification
Steroidal pure antiestrogen
Administration method
Intramuscular injection
Efficacy
Reduces the growth and progression of hormone receptor-positive breast cancer in postmenopausal women
Tolerance
Generally well tolerated
Common side effects
Injection site reactions, hot flashes, and headaches
Check Digit Verification of cas no
The CAS Registry Mumber 155271-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,2,7 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 155271-59:
(8*1)+(7*5)+(6*5)+(5*2)+(4*7)+(3*1)+(2*5)+(1*9)=133
133 % 10 = 3
So 155271-59-3 is a valid CAS Registry Number.
155271-59-3Relevant articles and documents
Therapeutic agent for Parkinson's disease
-
, (2008/06/13)
Agents for the treatment of Parkinson''s disease contain, as an active ingredient, a xanthine derivative or a pharmaceutically acceptable salt thereof. The xanthine derivative is represented by the formula: STR1 in which R 1, R 2 are R 3 are independently hydrogen, lower alkyl, lower alkenyl, or lower alkynyl; and R 4 represents cycloalkyl, --(CH 2) n --R 5 (in which R 5 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group; and n is an integer of 0 to 4), or STR2 in which Y 1 and Y 2 represent independently hydrogen, halogen, or lower alkyl; and Z represents substituted or unsubstituted aryl, STR3 in which R 6 represents hydrogen, hydroxy, lower alkyl, lower alkoxy, halogen, nitro, or amino; and m represents an integer of 1 to 4, or a substituted or unsubstituted heterocyclic group; and X 1 and X 2 represent independently O or S.